On top of that, different studies have linked PKM2 and its characterized non-metabolic functions, including its relocation to the nucleus and extracellular secretion, with cancer aggressiveness and promotion of metastasis (Zhu et al., 2017; Wang et al., 2020; Apostolidi et al., 2021). This evidence concerns the gene PKM and cancer.